When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Pfizer antiviral pills may be risky with other medications - AOL

   www.aol.com/news/pfizer-covid-pills-may-risky...

   As the omicron surge pummels a pandemic-weary nation, the first antiviral pills for Covid-19 promise desperately needed protection for people at risk of severe disease. However, many people ...

3. List of unproven methods against COVID-19 - Wikipedia

   en.wikipedia.org/wiki/List_of_unproven_methods...

   In March 2020, then US President Donald Trump promoted the use of chloroquine and hydroxychloroquine, two related anti-malarial drugs, for treating COVID-19. The FDA later clarified that it has not approved any therapeutics or drugs to treat COVID-19, but that studies were underway to see if chloroquine could be effective in treatment of COVID-19.

4. How Covid antiviral pills work and what that could mean for ...

   www.aol.com/covid-antiviral-pills-could-mean...

   Two drug companies have developed antiviral pills to fight Covid-19. They both work by blocking enzymes that play a role in how the virus replicates in the body.

5. Tested positive for Covid and at high risk? How to get ... - AOL

   www.aol.com/news/tested-positive-covid-high-risk...

   With at-home Covid-19 testing kits beginning to arrive in ... and both drugs come with risk of side effects for certain ... A full course of Merck’s treatment is a total of 40 pills, taken as ...

6. Ensitrelvir - Wikipedia

   en.wikipedia.org/wiki/Ensitrelvir

   Ensitrelvir has been investigated for use as potential post-exposure prophylaxis (PEP) for SARS-CoV-2 infection. [20] [21] The SCORPIO-PEP trial, a global Phase 3 study, assessed the safety and efficacy of ensitrelvir in preventing symptomatic COVID-19 among household contacts of individuals with confirmed SARS-CoV-2 infection.

7. Nirmatrelvir/ritonavir - Wikipedia

   en.wikipedia.org/wiki/Nirmatrelvir/ritonavir

   The co-packaged medication is not authorized or suggested for the pre-exposure or post-exposure prevention of COVID‑19. [12] [14] [30] In the European Union, the co-packaged medication is indicated for the treatment of COVID‑19 in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe COVID ...